Tianda Pharmaceuticals Limited (0455.HK)
0455.HK Stock Price Chart
Explore Tianda Pharmaceuticals Limited interactive price chart. Choose custom timeframes to analyze 0455.HK price movements and trends.
0455.HK Company Profile
Discover essential business fundamentals and corporate details for Tianda Pharmaceuticals Limited (0455.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
30 Mar 1992
Employees
701.00
Website
https://www.tiandapharma.comCEO
Wen Quan Fang
Description
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
0455.HK Financial Timeline
Browse a chronological timeline of Tianda Pharmaceuticals Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 6 Jun 2025
Earnings released on 28 Mar 2025
Earnings released on 31 Dec 2024
EPS came in at -$0.02 , while revenue for the quarter reached $173.86M .
Earnings released on 28 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $78.04M .
Earnings released on 7 Jun 2024
EPS came in at -$0.01 , while revenue for the quarter reached $228.61M .
Earnings released on 31 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $78.04M .
Earnings released on 30 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $114.30M .
Earnings released on 28 Aug 2023
EPS came in at -$0.00 , while revenue for the quarter reached $303.48M .
Earnings released on 28 Apr 2023
EPS came in at -$0.00 , while revenue for the quarter reached $151.74M .
Earnings released on 24 Mar 2023
Earnings released on 26 Nov 2022
Earnings released on 31 Mar 2022
EPS came in at -$0.00 , while revenue for the quarter reached $136.72M .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $136.72M .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $236.52M .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 , while revenue for the quarter reached $118.26M .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $286.97M .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 , while revenue for the quarter reached $143.48M .
Earnings released on 30 Sept 2020
EPS came in at -$0.01 , while revenue for the quarter reached $187.36M .
0455.HK Stock Performance
Access detailed 0455.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.